Peter Johnson to Substance Withdrawal Syndrome
This is a "connection" page, showing publications Peter Johnson has written about Substance Withdrawal Syndrome.
Connection Strength
1.842
-
Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016 12; 36(12):1290-1299.
Score: 0.513
-
Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012 Feb; 32(2):148-57.
Score: 0.367
-
Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. J Opioid Manag. 2010 Mar-Apr; 6(2):117-24.
Score: 0.321
-
Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009 Sep; 43(9):1506-11.
Score: 0.310
-
Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. A A Case Rep. 2017 May 01; 8(9):242-245.
Score: 0.132
-
Ketamine Continuous Infusions in Critically Ill Infants and Children. Ann Pharmacother. 2016 Mar; 50(3):234-41.
Score: 0.121
-
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010 Feb; 44(2):343-51.
Score: 0.079